The table below shows Altimmune, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
$5.00K
$5.00K
$5.00K
$5.00K
$5.00K
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$16.19M
$14.96M
$17.24M
$15.83M
$19.80M
$21.16M
SG&A
ALT annual revenue (10-K history)
Altimmune, Inc. reported annual revenue of $41.00K for fiscal year 2025. That is up 105.0% from $20.00K in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $3.24M (FY 2016) to $41.00K. Figures come from the company's audited annual reports as filed with the SEC.